Abstract
Small Intestinal Carcinoma: this chapter outlines the incidence, risk factors, clinical presentation, investigations, treatments and prognosis of cancer at this anatomical site. These features are correlated with the core data that are required to make the corresponding histopathology reports of a consistently high quality, available in an appropriate timeframe, and clinically relevant to patient management and prognosis. Summary details of the common cancers given at this site include: gross description, histological types, tumour grade/differentiation, extent of local tumour spread, lymphovascular invasion, lymph node involvement, and the status of excision margins. Current WHO Classifications of Malignant Tumours and TNM7 are referenced. Notes are provided on other associated pathology, contemporary use of immunohistochemistry, updates on the role of evolving molecular tests, and the use of these ancillary techniques as biomarkers in diagnosis, and prediction of prognosis and treatment response. A summary is given of the commoner non-carcinoma malignancies that are encountered at this site in diagnostic practice.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Bibliography
Banks PM. Gastrointestinal lymphoproliferative disorders. Histopathology. 2007;50:42–54.
Bosman FT, Carneiro F. WHO classification of tumours of the digestive system. 4th ed. Lyon: IARC press; 2010.
Day DW, Jass JR, Price AB, Shepherd NA, Sloan JM, Talbot IC, Warren BF, Williams GT. Morson and Dawson’s gastrointestinal pathology. 4th ed. Oxford: Blackwell Sciences; 2003.
Domizio P, Owen RA, Shepherd NA, Talbot IC, Norton AJ. Primary lymphoma of the small intestine. A clinicopathological study of 119 cases. Am J Surg Pathol. 1993;17:429–42.
Dudley H, Pories W, Carter D, editors. Rob and Smith’s operative surgery: alimentary tract and abdominal wall. 4th ed. London: Butterworths; 1993.
Hemminger J, Iwenofu OH. Discovered on gastrointestinal stromal tumours 1 (DOG1) expression in non-gastrointestinal stromal tumour (GIST) neoplasms. Histopathology. 2012;61:170–7.
Ho-Yen C, Chang F, van der Walt J, Mitchell T, Ciclitira P. Recent advances in refractory coeliac disease: a review. Histopathology. 2009;54:783–95.
Joensuu H. Risk stratification of patients diagnosed with gastrointestinal stromal tumor. Hum Pathol. 2008;39:1411–9.
Kanthan R, Gomez D, Senger J-L, Kantan SC. Endoscopic biopsies of duodenal polyp/mass lesions: a surgical pathology review. J Clin Pathol. 2010;63:921–5.
Lioe TF, Biggart JD. Primary adenocarcinoma of the jejunum and ileum: clinicopathological review of 25 cases. J Clin Pathol. 1990;43:533–6.
Miettinen M, Makhlouf H, Sobin LH, Lasota J. Gastrointestinal stromal tumors of the jejunum and ileum. A clinicopathologic, immunohistochemical, and molecular genetic study of 906 cases before imatinib with long-term follow-up. Am J Surg Pathol. 2006;30:477–89.
Novelli M, Rossi S, Rodriguez-Justo M, Taniere P, Seddon B, Toffolatti L, Sartor C, Hogendoorn PCW, Sciot R, van Glabbeke M, Verweij J, Blay JY, Hohenberger P, Flanagan A, Tos APD. DOG1 and CD117 are the antibodies of choice in the diagnosis of gastrointestinal stromal tumours. Histopathology. 2010;57:259–70.
Odze RD, Goldblum JR. Surgical pathology of the GI tract, liver, biliary tract and pancreas. 2nd ed. Philadelphia: Saunders/Elsevier; 2009.
Pauwels P, Debiec-Rychter M, Stul M, de Wever I, van Oosterom AT, Sciot R. Changing phenotype of gastrointestinal stromal tumours under imatinib mesylate treatment: a potential diagnostic pitfall. Histopathology. 2005;47:41–7.
Riddell RH, Petras RE, Williams GT, Sobin LH. Tumors of the intestines. Atlas of tumor pathology. 3rd Series. Fascicle 32. Washington: AFIP; 2003.
The Royal College of Pathologists: Cancer Datasets (Oesophageal Carcinoma, Gastric Carcinoma, Carcinomas of the Pancreas, ampulla of Vater and Common Bile Duct, Colorectal Cancer, Gastrointestinal Stromal Tumours (GISTs), Liver Resection Specimens and Liver Biopsies for Primary and Metastatic Carcinoma, Endocrine Tumours of the Gastrointestinal Tract including Pancreas) and Tissue Pathways (Gastrointestinal and Pancreatobiliary Pathology, Liver Biopsies for the Investigation of Medical Disease and for Focal Liver Lesions). Accessed at http://www.rcpath.org/index.asp?PageID=254.
Walker MM, Murray JA. An update in the diagnosis of coeliac disease. Histopathology. 2011;59:166–79.
Williams GT. Endocrine tumours of the gastrointestinal tract – selected topics. Histopathology. 2007;50:30–41.
Wittekind CF, Greene FL, Hutter RVP, Klimpfinger M, Sobib LH. TNM atlas: illustrated guide to the TNM/pTNM classification of malignant tumours. 5th ed. Berlin: Springer; 2005.
Wong NACS. Gastrointestinal stromal tumours – an update for histopathologists. Histopathology. 2011;59:807–21.
Wong NACS, Deans ZC, Ramsden SC. The UK NEQUAS for molecular genetics scheme for gastrointestinal stromal tumour: findings and recommendations following four rounds of circulation. J Clin Pathol. 2012;65:786–90.
Yantis RK, Odze RD. Neoplastic precursor lesions of the upper gastrointestinal tract. Diagn Histopathol. 2008;14:437–52.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag London
About this chapter
Cite this chapter
Allen, D.C. (2013). Small Intestinal Carcinoma. In: Histopathology Reporting. Springer, London. https://doi.org/10.1007/978-1-4471-5263-7_4
Download citation
DOI: https://doi.org/10.1007/978-1-4471-5263-7_4
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-4471-5262-0
Online ISBN: 978-1-4471-5263-7
eBook Packages: MedicineMedicine (R0)